This study tests a combination of an immunotherapy drug (cemiplimab) and two low-dose chemotherapy drugs (paclitaxel and carboplatin) in people with head and neck cancer that has returned or spread. The goal is to see if this mix can shrink tumors better than standard treatments.…
Phase: PHASE2 • Sponsor: Marcelo Bonomi • Aim: Disease control
Last updated May 08, 2026 12:01 UTC